Oscar Health amends CEO Bertolini's employment agreement; $45M equity grant, base salary $1.3M

Oscar Health, Inc.

New term from Dec 22, 2025 to Apr 1, 2029, with automatic one-year renewals unless either party elects not to extend.
Annual base salary set at $1.3M; target bonus increased to 150% of base starting in 2026.
$45M in RSU awards granted Q1 2026: 50% time-vesting over three years, 50% performance-based.
Enhanced severance: 1.5x cash multiplier and 18 months of healthcare upon without-cause or good reason termination.
Mr. Bertolini not eligible for other long-term equity awards until calendar year 2029.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.